Skip to main content
Erschienen in: Endocrine 3/2023

24.06.2023 | Original Article

Role of adrenal venous sampling in the differential diagnosis and treatment protocol of ACTH-independent Cushing’s syndrome with bilateral adrenal lesions

verfasst von: Xingxing An, Tao Chen, Dan Mo, Sikui Shen, Dan Zhang, Tingting Zhang, Haoming Tian, Yuanmei Li, Jianwei Li, Li Li, Nianwei Wu, Yuchun Zhu, Yan Ren

Erschienen in: Endocrine | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The diagnosis and management of adrenocorticotropic hormone-independent Cushing’s syndrome (AICS) with bilateral adrenal lesions remain challenging. Some studies have explored the value of adrenal vein sampling (AVS) in patients with AICS; however, more investigations are needed to assess its benefits for diagnosis and treatment planning in this population.

Methods

Thirteen patients with clinical, biochemical and imaging evidence of AICS with bilateral adrenal lesions underwent AVS in our department from 2017–2022 were recruited. Only the data from nine patients for whom AVS succeeded were finally included in this study and further analyzed. Blood samples were successfully collected from both adrenal veins (AV) and inferior vena cava (IVC) in these nine patients, and the levels of plasma total cortisol (PTC) and plasma aldosterone concentrations (PAC) were measured. The ratio of the PAC of the AV to the IVC was calculated, and the PTC to PAC ratios were compared between AV. The surgical strategy was chosen according to the results of AVS. Postoperative histology and immunohistochemistry of the adrenal tissues were performed. The prognosis was evaluated based on the improvement of clinical symptoms and biochemical parameters (including PTC and ACTH measurements).

Results

Patients with AICS were clinically diagnosed based on clinical signs, results of functional tests and the presence of bilateral adrenal lesions as observed on computed tomography imaging. An AV to IVC PAC ratio greater than 2 confirmed successful AVS. The PTC to PAC ratio (high side to low side) was greater than 2 in four patients, and less than 2 in five patients. The postoperative pathological results were consistent with clinical diagnosis and AVS. During the mean follow-up of 33 months, all nine patients achieved varying degrees of clinical improvement.

Conclusion

Our study showed that AVS helped to distinguish unilateral and bilateral lesions, identify the laterality of the autonomous hypercortisolism, and improve therapeutic strategy selection in patients with AICS and bilateral adrenal lesions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386, 913–927 (2015)CrossRefPubMed A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386, 913–927 (2015)CrossRefPubMed
2.
Zurück zum Zitat A. Lacroix, I. Bourdeau, Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol. Metab. Clin. North Am. 34, 441–458 (2005). xCrossRefPubMed A. Lacroix, I. Bourdeau, Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol. Metab. Clin. North Am. 34, 441–458 (2005). xCrossRefPubMed
3.
Zurück zum Zitat I. Bourdeau, N. El Ghorayeb, N. Gagnon, A. Lacroix, MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur. J. Endocrinol. 179, R57–r67 (2018)CrossRefPubMed I. Bourdeau, N. El Ghorayeb, N. Gagnon, A. Lacroix, MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur. J. Endocrinol. 179, R57–r67 (2018)CrossRefPubMed
4.
Zurück zum Zitat Stratakis CA. Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasias (Corticotropin- Independent Cushing Syndrome). Stratakis CA. Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasias (Corticotropin- Independent Cushing Syndrome).
5.
Zurück zum Zitat W.F. Young Jr, H. du Plessis, G.B. Thompson, C.S. Grant, D.R. Farley, M.L. Richards, D. Erickson, A. Vella, A.W. Stanson, J.A. Carney, C.F. Abboud, P.C. Carpenter, The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J. Surg. 32, 856–862 (2008)CrossRefPubMed W.F. Young Jr, H. du Plessis, G.B. Thompson, C.S. Grant, D.R. Farley, M.L. Richards, D. Erickson, A. Vella, A.W. Stanson, J.A. Carney, C.F. Abboud, P.C. Carpenter, The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J. Surg. 32, 856–862 (2008)CrossRefPubMed
6.
Zurück zum Zitat J. Wei, S. Li, Q. Liu, Y. Zhu, N. Wu, Y. Tang, Q. Li, K. Ren, Q. Zhang, Y. Yu, Z. An, J. Chen, J. Li, ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. BMC Endocr. Disord. 18, 22 (2018)CrossRefPubMedPubMedCentral J. Wei, S. Li, Q. Liu, Y. Zhu, N. Wu, Y. Tang, Q. Li, K. Ren, Q. Zhang, Y. Yu, Z. An, J. Chen, J. Li, ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. BMC Endocr. Disord. 18, 22 (2018)CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat P. Raje, J.M. Broekhuis, B.A. Sacks, B.C. James, Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing’s Syndrome. J. Surg. Res. 268, 660–666 (2021)CrossRefPubMed P. Raje, J.M. Broekhuis, B.A. Sacks, B.C. James, Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing’s Syndrome. J. Surg. Res. 268, 660–666 (2021)CrossRefPubMed
8.
Zurück zum Zitat X. An, G. Liao, Y. Chen, A. Luo, J. Liu, Y. Yuan, L. Li, L. Yang, H. Wang, F. Liu, G. Yang, S. Yi, Y. Li, J. Cheng, Y. Lu, Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model. Stem Cell Res Ther. 10, 363 (2019)CrossRefPubMedPubMedCentral X. An, G. Liao, Y. Chen, A. Luo, J. Liu, Y. Yuan, L. Li, L. Yang, H. Wang, F. Liu, G. Yang, S. Yi, Y. Li, J. Cheng, Y. Lu, Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model. Stem Cell Res Ther. 10, 363 (2019)CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Y. Nakamura, M. Kitada, F. Satoh, T. Maekawa, R. Morimoto, Y. Yamazaki, K. Ise, C.E. Gomez-Sanchez, S. Ito, Y. Arai, M. Dezawa, H. Sasano, Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17. Mol. Cell Endocrinol. 422, 57–63 (2016)CrossRefPubMed Y. Nakamura, M. Kitada, F. Satoh, T. Maekawa, R. Morimoto, Y. Yamazaki, K. Ise, C.E. Gomez-Sanchez, S. Ito, Y. Arai, M. Dezawa, H. Sasano, Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17. Mol. Cell Endocrinol. 422, 57–63 (2016)CrossRefPubMed
10.
Zurück zum Zitat L. Sun, Y. Jiang, J. Xie, H. Zhu, L. Wu, X. Zhong, W. Zhou, T. Su, W. Wang, Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism. Front Mol. Biosci. 8, 751770 (2021)CrossRefPubMedPubMedCentral L. Sun, Y. Jiang, J. Xie, H. Zhu, L. Wu, X. Zhong, W. Zhou, T. Su, W. Wang, Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism. Front Mol. Biosci. 8, 751770 (2021)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 100, 2807–2831 (2015)CrossRefPubMedPubMedCentral L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 100, 2807–2831 (2015)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat G. Rubinstein, A. Osswald, L.T. Braun, F. Vogel, M. Kroiss, S. Pilz, S. Deniz, L. Aigner, T. Knösel, J. Bertherat, L. Bouys, R. Ladurner, A. Riester, M. Bidlingmaier, F. Beuschlein, M. Reincke, The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients. Endocrine. 76, 434–445 (2022)CrossRefPubMedPubMedCentral G. Rubinstein, A. Osswald, L.T. Braun, F. Vogel, M. Kroiss, S. Pilz, S. Deniz, L. Aigner, T. Knösel, J. Bertherat, L. Bouys, R. Ladurner, A. Riester, M. Bidlingmaier, F. Beuschlein, M. Reincke, The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients. Endocrine. 76, 434–445 (2022)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat R.G. Martins, R. Agrawal, D.M. Berney, R. Reznek, M. Matson, A.B. Grossman, M.R. Druce, Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling. Endocr. Pr. 18, e153–157 (2012)CrossRef R.G. Martins, R. Agrawal, D.M. Berney, R. Reznek, M. Matson, A.B. Grossman, M.R. Druce, Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling. Endocr. Pr. 18, e153–157 (2012)CrossRef
14.
Zurück zum Zitat W.F. Young, A.W. Stanson. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clinical Endocrinol. 70, 14–17(2010 W.F. Young, A.W. Stanson. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clinical Endocrinol. 70, 14–17(2010
15.
Zurück zum Zitat D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization. World J. Surg. 40, 683–689 (2016)CrossRefPubMedPubMedCentral D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization. World J. Surg. 40, 683–689 (2016)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat T. Seki, A. Yasuda, N. Kitajima, M. Oki, A. Takagi, N. Nakamura, K. Hanai, T. Terachi, M. Fukagawa, Adrenal Venous Sampling Is Useful for a Definitive Diagnosis in Cushing’s Syndrome with Bilateral Adrenal Tumors. Tokai J. Exp. Clin. Med. 40, 149–156 (2015)PubMed T. Seki, A. Yasuda, N. Kitajima, M. Oki, A. Takagi, N. Nakamura, K. Hanai, T. Terachi, M. Fukagawa, Adrenal Venous Sampling Is Useful for a Definitive Diagnosis in Cushing’s Syndrome with Bilateral Adrenal Tumors. Tokai J. Exp. Clin. Med. 40, 149–156 (2015)PubMed
Metadaten
Titel
Role of adrenal venous sampling in the differential diagnosis and treatment protocol of ACTH-independent Cushing’s syndrome with bilateral adrenal lesions
verfasst von
Xingxing An
Tao Chen
Dan Mo
Sikui Shen
Dan Zhang
Tingting Zhang
Haoming Tian
Yuanmei Li
Jianwei Li
Li Li
Nianwei Wu
Yuchun Zhu
Yan Ren
Publikationsdatum
24.06.2023
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03395-7

Weitere Artikel der Ausgabe 3/2023

Endocrine 3/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.